Thomas J. Kipps

机构：University of California San Diego · ORCID：0000-0002-0064-4549

发表论文 1045 篇 · 总被引 64415 次 · h-index 121

代表论文

Dual targeting of ROR1 and ROR2 with glycoengineered antibodies elicits potent and selective immunotherapy in hairy cell leukemia (2025 · Blood · 被引 1)
Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis (2025 · Cell Death and Disease · 被引 1)
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004 (2026 · Blood)
Data from Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis (2026)
Figure 1 from Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis (2026)
Table 1 from Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis (2026)